Since the FDA approved the first monoclonal based therapy in 1985, mAbs have had significant clinical success and have been used to provide effective treat...

As cell therapy rapidly progresses, tumor infiltrating lymphocyte (TIL) therapies are playing a significant role in shaping the field. What milestones ena...

Advances in molecular and immunodiagnostics are enabling a personalized, high-precision approach to health in many clinical areas. But how will this conti...

Join Linda Mathiasson, Strategic Customer Leader for Nucleic Acid Therapeutics at Cytiva, to look at the history of mRNA immunotherapy, cancer vaccine mod...

As regulations become more stringent, microbiological testing and analyses are critical to ensure the quality of pharmaceutical products. The membrane filt...

Automate your impurity ELISA testing using Cytiva Impurity ELISA kits and Beckman Biomek i5 liquid handling systems.

The Cytiva Security of Supply program applies a data-driven approach to identify and reduce supply chain risk. It encompasses business continuity managemen...

Take a deep dive into nitrocellulose membranes including the raw material, structure manufacturing process and capillary flow time and how these affect you...

When selecting materials for immunoassay development, membrane properties, and reagent properties must be considered together, as their interactions determ...

In this webinar, we’ll discuss our journey in becoming the first GMP-certified cell and gene therapy manufacturing facility in Thailand. During the journey...